Abstract | OBJECTIVE: DESIGN: Randomized, prospective, controlled clinical trial. PARTICIPANTS: One hundred nine patients who had undergone pterygium excision within the previous 6 months and developed grade 3 characteristics (impending recurrent pterygium). METHODS: MAIN OUTCOME MEASURES: Recurrence rate, success rate, and survival analysis were compared among the groups. RESULTS: With a mean follow-up time of 10.9+/-5.5 months (range, 6-26 months), the success rates of the 5-fluorouracil and triamcinolone groups were higher than the control group (87.2%, 71.4%, and 48.6%, respectively). 5-fluorouracil was significantly (P = 0.001) more effective in inhibiting the recurrence of pterygium compared with the control group at all time points during follow-up. Kaplan-Meier survival analysis showed that the recurrence-free period of pterygium in the 5-FU group was significantly (P = 0.005) longer than that of the control group but not in the triamcinolone group compared with the controls (P = 0.063). There was no significant difference between the 5-FU group and the triamcinolone group (P = 0.362). Minimal reversible complications such as steroid-induced glaucoma and superficial punctate epitheliopathy developed during the study. CONCLUSIONS:
|
Authors | Pinnita Prabhasawat, Nattaporn Tesavibul, Kanjana Leelapatranura, Teeranit Phonjan |
Journal | Ophthalmology
(Ophthalmology)
Vol. 113
Issue 7
Pg. 1102-9
(Jul 2006)
ISSN: 1549-4713 [Electronic] United States |
PMID | 16730066
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antimetabolites, Antineoplastic
- Glucocorticoids
- Triamcinolone Acetonide
- Fluorouracil
|
Topics |
- Adult
- Aged
- Antimetabolites, Antineoplastic
(administration & dosage)
- Conjunctiva
- Disease Progression
- Female
- Fluorouracil
(administration & dosage)
- Follow-Up Studies
- Glucocorticoids
(administration & dosage)
- Humans
- Injections
- Injections, Intralesional
- Male
- Middle Aged
- Prospective Studies
- Pterygium
(prevention & control, surgery)
- Recurrence
- Survival Analysis
- Treatment Outcome
- Triamcinolone Acetonide
(administration & dosage)
|